anti-SLAMF7 CAR T-cell therapy (University of Wuerzburg)

N/A

Report date: 2025/03/14 16:35:31

Base Information

Drug Nameanti-SLAMF7 CAR T-cell therapy (University of Wuerzburg)
Drug Alias Nameanti-CS1 CAR T-cell therapy (University of Wuerzburg)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionSLAM family member 7 modulators
TargetsSLAM family member 7
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Hospital of Wurzburg
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Hospital of Wurzburg
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A